Citations (64)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Sten Holmäng & Sonny L. Johansson. (2006) Impact of diagnostic and treatment delay on survival in patients with renal pelvic and ureteral cancer. Scandinavian Journal of Urology and Nephrology 40:6, pages 479-484.
Read now
Read now
Hans Hedelin, Karin Jonsson, Karin Salomonsson & Hans Boman. (2006) Screening for bladder tumours in men aged 60–70 years with a bladder tumour marker (UBC) and dipstick-detected haematuria using both white-light and fluorescence cystoscopy. Scandinavian Journal of Urology and Nephrology 40:1, pages 26-30.
Read now
Read now
Fredrik Liedberg, Harald Anderson, Åsa Månsson & Wiking Månsson. (2003) Diagnostic delay and prognosis in invasive bladder cancer. Scandinavian Journal of Urology and Nephrology 37:5, pages 396-400.
Read now
Read now
Å. Månsson, H. Anderson & S. Colleen. (1993) Time Lag to Diagnosis of Bladder Cancer–Influence of Psychosocial Parameters and Level of Health-Care Provision. Scandinavian Journal of Urology and Nephrology 27:3, pages 363-369.
Read now
Read now
Articles from other publishers (60)
Sung Jin Kim, Myungchan Park & Sangjun Yoo. (2023) Urologic malignancies that cause hematuria. Journal of the Korean Medical Association 66:6, pages 363-373.
Crossref
Crossref
Rahul Gupta, Suhail M Khan, Manik Mahajan, Poonam Sharma & Arti Mahajan. (2023) Urinary Bladder Carcinoma in Females: A Clinico-Pathological Assessment. Cureus.
Crossref
Crossref
Elliott Freudenburg, Yong Shan, Ariza Martinez, Aditya Srinivasan, Giri Movva, Alexander Yu, Mohanad AlBayyaa, Zachary Klaassen, Stephen J. Freedland, Ashish M. Kamat & Stephen B. Williams. (2022) Geographic distribution of racial differences in mortality in muscle-invasive bladder cancer patients: an opportunity for improvement. Cancer Causes & Control 33:4, pages 613-622.
Crossref
Crossref
Hasan Basri ÇETİNKAYA & Harun GÜNEŞ. (2021) Prediction of hospitalization and blood transfusion requirement in patients with macroscopic hematuria. Anatolian Current Medical Journal 3:4, pages 315-318.
Crossref
Crossref
Richard T. Bryan, James W.F. Catto, Kieran P. Jefferson, Prashant Patel, Nicholas D. James & on behalf of the BladderPath Trial Management Group. (2021) Reply to Trey Durdin, Alvin Goh, and Eugene Pietzak. Can an Imaging-guided Pathway Replace the Current Paradigm for Muscle-invasive Bladder Cancer?. European Urology 80:1, pages 18-19.
Crossref
Crossref
Laura Bukavina, Megan Prunty, Kirtishri Mishra, Helen Sun, David Sheyn, Britt Conroy, Amr Mahran, Gregory MacLennan, Fredrick Schumacher, Lee Ponsky & Sarah Markt. (2021) Gender Disparities in Bladder Cancer-Specific Survival in High Poverty Areas Utilizing Ohio Cancer Incidence Surveillance System (OCISS). Urology 151, pages 163-168.
Crossref
Crossref
Laura Bukavina, Kirtishri Mishra, Amr Mahran, Anjali Shekar, David Sheyn, Emily Slopnick, Adoniz Hijaz, Jason Jankowski, Lee Ponsky & Carvell Nguyen. (2021) Gender Disparity in Cystectomy Postoperative Outcomes: Propensity Score Analysis of the National Surgical Quality Improvement Program Database. European Urology Oncology 4:1, pages 84-92.
Crossref
Crossref
Juan C. Herrera, Christine Ibilibor, Hanzhang Wang, Geraldine T. Klein, Ahmed Elshabrawy, Wasim H. Chowdhury, Dharam Kaushik, Michael Liss, Robert Svatek & Ahmed M. Mansour. (2020) National Trends and Impact of Regionalization of Radical Cystectomy on Survival Outcomes in Patients with Muscle Invasive Bladder Cancer. Clinical Genitourinary Cancer 18:6, pages e762-e770.
Crossref
Crossref
Antonieta Medina-Lara, Bogdan Grigore, Ruth Lewis, Jaime Peters, Sarah Price, Paolo Landa, Sophie Robinson, Richard Neal, William Hamilton & Anne E Spencer. (2020) Cancer diagnostic tools to aid decision-making in primary care: mixed-methods systematic reviews and cost-effectiveness analysis. Health Technology Assessment 24:66, pages 1-332.
Crossref
Crossref
Ville Sell, Otto Ettala, Ileana Montoya Perez, Riikka Järvinen, Tarmo Pekkarinen, Markku Vaarala, Marjo Seppänen, Tapani Liukkonen, Timo Marttila, Sirpa Aaltomaa, Eero Kaasinen & Peter J. Boström. (2019) Symptoms and diagnostic delays in bladder cancer with high risk of recurrence: results from a prospective FinnBladder 9 trial. World Journal of Urology 38:4, pages 1001-1007.
Crossref
Crossref
Ji Sung Shim, Ho Kyung Seo, Ja Hyeon Ku, Byong Chang Jeong, Bumsik Hong & Seok Ho Kang. (2019) Oncologic, Perioperative Outcomes of Female Radical Cystectomy: Results from a Multicenter Study in Korea. Cancer Research and Treatment 51:3, pages 1064-1072.
Crossref
Crossref
Christopher Kwesi O. WilliamsChristopher Kwesi O. Williams. 2019. Cancer and AIDS. Cancer and AIDS
3
63
.
David S. Han, Weiping Zhou, John D. Seigne, Kristine E. Lynch & Florian R. Schroeck. (2018) Geographic Variation in Cystoscopy Rates for Suspected Bladder Cancer between Female and Male Medicare Beneficiaries. Urology 122, pages 83-88.
Crossref
Crossref
Annemarie Uhlig, Arne Strauss, Ali Seif Amir Hosseini, Joachim Lotz, Lutz Trojan, Marianne Schmid & Johannes Uhlig. (2018) Gender-specific Differences in Recurrence of Non–muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis. European Urology Focus 4:6, pages 924-936.
Crossref
Crossref
Stephen B. Williams, Jinhai Huo, Tamer J. Dafashy, Cameron K. Ghaffary, Jacques G. Baillargeon, Edwin E. Morales, Simon P. Kim, Yong-Fang Kuo, Eduardo Orihuela, Douglas S. Tyler, Stephen J. Freedland & Ashish M. Kamat. (2017) Survival differences among patients with bladder cancer according to sex: Critical evaluation of radical cystectomy use and delay to treatment. Urologic Oncology: Seminars and Original Investigations 35:10, pages 602.e1-602.e9.
Crossref
Crossref
Brian Ngo, Marlon Perera, Nathan Papa, Damien Bolton & Shomik Sengupta. (2017) Factors affecting the timeliness and adequacy of haematuria assessment in bladder cancer: a systematic review. BJU International 119, pages 10-18.
Crossref
Crossref
Brian Ngo, Nathan Papa, Marlon Perera, Damien Bolton & Shomik Sengupta. (2017) Predictors of delay to cystoscopy and adequacy of investigations in patients with haematuria. BJU International 119, pages 19-25.
Crossref
Crossref
Jong Chul Park, Nilay M. Gandhi, Michael A. Carducci, Mario A. Eisenberger, Alexander S. Baras, George J. Netto, Jen-Jane Liu, Charles G. Drake, Mark P. Schoenberg, Trinity J. Bivalacqua & Noah M. Hahn. (2016) A Retrospective Analysis of the Effect on Survival of Time from Diagnosis to Neoadjuvant Chemotherapy to Cystectomy for Muscle Invasive Bladder Cancer. Journal of Urology 195:4 Part 1, pages 880-885.
Crossref
Crossref
Frances Burge & Roger Kockelbergh. (2016) Closing the Gender Gap: Can We Improve Bladder Cancer Survival in Women? - A Systematic Review of Diagnosis, Treatment and Outcomes. Urologia Internationalis 97:4, pages 373-379.
Crossref
Crossref
M. Ariane, P. Meria & F. Desgranchamps. (2015) Ematuria (non traumatica nell’adulto). EMC - Urgenze 19:4, pages 1-7.
Crossref
Crossref
R D Neal, P Tharmanathan, B France, N U Din, S Cotton, J Fallon-Ferguson, W Hamilton, A Hendry, M Hendry, R Lewis, U Macleod, E D Mitchell, M Pickett, T Rai, K Shaw, N Stuart, M L Tørring, C Wilkinson, B Williams, N Williams & J Emery. (2015) Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. British Journal of Cancer 112:S1, pages S92-S107.
Crossref
Crossref
JH Gan, AC Harris & JSA Green. (2014) Quantifying the risk of malignancy in patients with visible haematuria presenting to the emergency department. Journal of Clinical Urology 8:2, pages 132-138.
Crossref
Crossref
Jamie C. Messer, Shahrokh F. Shariat, Colin P. Dinney, Giacomo Novara, Yves Fradet, Wassim Kassouf, Pierre I. Karakiewicz, Hans-Martin Fritsche, Jonathan I. Izawa, Yair Lotan, Eila C. Skinner, Derya Tilki, Vincenzo Ficarra, Bjoern G. Volkmer, Hendrik Isbarn, Caimiao Wei, Seth P. Lerner, Tyler J. Curiel, Ashish M. Kamat & Robert S. Svatek. (2014) Female Gender Is Associated With a Worse Survival After Radical Cystectomy for Urothelial Carcinoma of the Bladder: A Competing Risk Analysis. Urology 83:4, pages 863-868.
Crossref
Crossref
Elizabeth A Shephard, Sally Stapley, Richard D Neal, Peter Rose, Fiona M Walter & William T Hamilton. (2012) Clinical features of bladder cancer in primary care. British Journal of General Practice 62:602, pages e598-e604.
Crossref
Crossref
James P Guevara, Diane Hsu & Christopher B Forrest. (2011) Performance measures of the specialty referral process: a systematic review of the literature. BMC Health Services Research 11:1.
Crossref
Crossref
Alan M. Nieder, Yair Lotan, Geoffrey R. Nuss, Joshua P. Langston, Sachin Vyas, Murugesan Manoharan & Mark S. Soloway. (2010) Are patients with hematuria appropriately referred to Urology? A multi-institutional questionnaire based survey. Urologic Oncology: Seminars and Original Investigations 28:5, pages 500-503.
Crossref
Crossref
U Macleod, E D Mitchell, C Burgess, S Macdonald & A J Ramirez. (2009) Risk factors for delayed presentation and referral of symptomatic cancer: evidence for common cancers. British Journal of Cancer 101:S2, pages S92-S101.
Crossref
Crossref
Kathleen F. Brookfield, Michael C. Cheung, Christopher Gomez, Relin Yang, Alan M. Nieder, David J. Lee & Leonidas G. Koniaris. (2009) Survival disparities among African American women with invasive bladder cancer in Florida. Cancer 115:18, pages 4196-4209.
Crossref
Crossref
V. Varca, A. Simonato, P. Traverso, A. Romagnoli, F. Venzano, M. Esposito, E. Rikani, C. Ambruosi & G. Carmignani. (2018) Disease Progression in Bladder Cancer: Which Developments since 1994. Urologia Journal 76:2, pages 115-117.
Crossref
Crossref
M. Mantle, A. J. Dickinson, M. Moody & R. Cox. (2009) How Quickly are We Treating Muscle Invasive Bladder Cancer? Trends over a 17 Year Period. British Journal of Medical and Surgical Urology 2:1, pages 22-26.
Crossref
Crossref
D Hicks & C-Y Li. (2008) Management of macroscopic haematuria in the emergency department. Postgraduate Medical Journal 84:996, pages 539-544.
Crossref
Crossref
Emilie K. Johnson, Stephanie Daignault, Yingxi Zhang & Cheryl T. Lee. (2008) Patterns of Hematuria Referral to Urologists: Does a Gender Disparity Exist?. Urology 72:3, pages 498-502.
Crossref
Crossref
Alan M. Nieder. (2008) Commentary on Association of Clinical Prostate and Bladder Cancers. Journal of Urology 179:5S.
Crossref
Crossref
Alan M. Nieder, Jill A. MacKinnon, Youjie Huang, Lora E. Fleming, Leonidas G. Koniaris & David J. Lee. (2008) Florida Bladder Cancer Trends 1981 to 2004: Minimal Progress in Decreasing Advanced Disease. Journal of Urology 179:2, pages 491-495.
Crossref
Crossref
Matthew E. Nielsen, Ganesh S. Palapattu, Pierre I. Karakiewicz, Yair Lotan, Patrick J. Bastian, Seth P. Lerner, Arthur I. Sagalowsky, Mark P. Schoenberg & Shahrokh F. Shariat. (2007) A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome. BJU International 100:5, pages 1015-1020.
Crossref
Crossref
Motoo Araki, Alan M. Nieder, Murugesan Manoharan, Yulong Yang & Mark S. Soloway. (2007) Lack of Progress in Early Diagnosis of Bladder Cancer. Urology 69:2, pages 270-274.
Crossref
Crossref
Nader M. Fahmy, Salaheddin Mahmud & Armen G. Aprikian. (2006) Delay in the Surgical Treatment of Bladder Cancer and Survival: Systematic Review of the Literature. European Urology 50:6, pages 1176-1182.
Crossref
Crossref
Salaheddin M. Mahmud, Brian Fong, Nader Fahmy, Simon Tanguay & Armen G. Aprikian. (2006) Effect of Preoperative Delay on Survival in Patients With Bladder Cancer Undergoing Cystectomy in Quebec. The Journal of Urology 175:1, pages 78???83.
Crossref
Crossref
Salaheddin M. Mahmud, Brian Fong, Nader Fahmy, Simon Tanguay & Armen G. Aprikian. (2006) Effect of Preoperative Delay on Survival in Patients With Bladder Cancer Undergoing Cystectomy in Quebec: A Population Based Study. Journal of Urology 175:1, pages 78-83.
Crossref
Crossref
FREDRIK LIEDBERG, HARALD ANDERSON & WIKING MÅNSSON. (2005) TREATMENT DELAY AND PROGNOSIS IN INVASIVE BLADDER CANCER. Journal of Urology 174:5, pages 1777-1781.
Crossref
Crossref
Ralph Madeb & Edward M. Messing. (2004) Gender, racial and age differences in bladder cancer incidence and mortality. Urologic Oncology: Seminars and Original Investigations 22:2, pages 86-92.
Crossref
Crossref
R. Chahal & S.C.W. Harrison. (2003) Re: An Interval Longer than 12 Weeks Between the Diagnosis of Muscle Invasion and Cystectomy is Associated with Worse Outcome in Bladder Carcinoma. Journal of Urology 170:4 Part 1, pages 1326-1327.
Crossref
Crossref
K R Subramonian, S Puranik & G R Mufti. (2017) How will the Two-Weeks-Wait Rule Affect Delays in Management of Urological Cancers?. Journal of the Royal Society of Medicine 96:8, pages 398-399.
Crossref
Crossref
CLIFFORD Y. WAI & DAVID SCOTT MILLER. (2002) Urinary Bladder Cancer. Clinical Obstetrics and Gynecology 45:3, pages 844-854.
Crossref
Crossref
D.M.A. Wallace, R.T. Bryan, J.A. Dunn, G. Begum & S. Bathers. (2002) Delay and survival in bladder cancer. BJU International 89:9, pages 868-878.
Crossref
Crossref
George R. Prout, Margaret N. Wesley, Raymond S. Greenberg, Vivien W. Chen, Charles C. Brown, Alex W. Miller, Ronald S. Weinstein, Stanley J. Robboy, M. Alfred Haynes, Robert S. Blacklow & Brenda K. Edwards. (2000) Bladder cancer. Cancer 89:6, pages 1349-1358.
Crossref
Crossref
N.Aydin Mungan, Lambertus A.L.M Kiemeney, Jos A.A.M van Dijck, Henk G van der Poel & J.Alfred Witjes. (2000) Gender differences in stage distribution of bladder cancer. Urology 55:3, pages 368-371.
Crossref
Crossref
C. L. BAKER. (1999) THE QUALITY OF MEDICAL TEXTBOOKS. The Journal of Urology, pages 223-229.
Crossref
Crossref
C.L. BAKER. (1999) THE QUALITY OF MEDICAL TEXTBOOKS: BLADDER CANCER DIAGNOSIS AS A CASE STUDY. Journal of Urology 161:1, pages 223-229.
Crossref
Crossref
D. A. COLLIE, A. B. PAUL & S. R. WILD. (2008) The diagnostic yield of intravenous urography: a demographic study. British Journal of Urology 73:6, pages 603-606.
Crossref
Crossref
S.T. HASAN, K. GERMAN & CD. DERRY. (2008) Same day diagnostic service for new cases of haematuria – a District General Hospital experience. British Journal of Urology 73:2, pages 152-154.
Crossref
Crossref
T. H. LYNCH, B. WAYMONT, J. A. DUNN, M. A. HUGHES & D. M. A. WALLACE. (2008) Rapid diagnostic service for patients with haematuria. British Journal of Urology 73:2, pages 147-151.
Crossref
Crossref
L.A.L.M. Kiemeney, J.W.W. Coebergh, N.P. Koper, L.H. van der Heijden, R.P.E. Pauwels, R.F.M. Schapers & A.L.M. Verbeek. (1994) Bladder cancer incidence and survival in the south-eastern part of the Netherlands, 1975–1989. European Journal of Cancer 30:8, pages 1134-1137.
Crossref
Crossref
P. D. ABEL. (1993) Follow-up of Patients with “Superficial” Transitional Cell Carcinoma of the Bladder: the Case for a Change in Policy. British Journal of Urology 72:2, pages 135-142.
Crossref
Crossref
A B Paul, D A Collie, S R Wild & G D Chisholm. (1993) AN INTEGRATED HAEMATURIA CLINIC. International Journal of Clinical Practice 47:3, pages 128-130.
Crossref
Crossref
J. P. BRITTON. (2008) Effectiveness of Haematuria Clinics. British Journal of Urology 71:3, pages 247-252.
Crossref
Crossref
. (1991) Correction: Physiotherapy for stress urinary incontinence: a national survey. BMJ 303:6800, pages 440-440.
Crossref
Crossref
M C Gulliford, A Petruckevitch & P G Burney. (1991) Survival with bladder cancer, evaluation of delay in treatment, type of surgeon, and modality of treatment.. BMJ 303:6800, pages 437-440.
Crossref
Crossref
Paul A. Williams. (1987) The role of staging in urologic cancer. Physical assessment and risk factors. Cancer 60:S3, pages 439-449.
Crossref
Crossref
D. M. A. Wallace. 1985. Bladder Cancer. Bladder Cancer
77
85
.